The brain and cytokines - the mutual origin of depression, obesity and cardiovascular diseases?

被引:8
作者
Ufnal, Marcin [1 ]
Wolynczyk-Gmaj, Dorota [2 ]
机构
[1] Warszawski Uniwersytet Med, Katedra & Zaklad Fizjol Doswiadczalnej & Klin, Warsaw, Poland
[2] Warszawski Uniwersytet Med, Katedra & Klin Psychiat, Warsaw, Poland
来源
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ | 2011年 / 65卷
关键词
cytokines; brain; inflammation; cardiovascular diseases; depression; obesity; hypertension; myocardial infarction; heart failure; TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; CENTRALLY ADMINISTERED INTERLEUKIN-1-BETA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; CILIARY NEUROTROPHIC FACTOR; CENTRAL PRESSOR ACTION; FACTOR-ALPHA; TNF-ALPHA; ANGIOTENSIN-II; BLOOD-PRESSURE;
D O I
10.5604/17322693.939284
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Accumulating evidence points to a pivotal role of the brain in the regulation of the circulatory system and energy balance. It has also been found that common civilization diseases such as depression, obesity, hypertension, myocardial infarction or heart failure are accompanied by an increase in concentration of inflammatory mediators in the blood, cerebrospinal fluid and various tissues. Recent studies have revealed that inflammatory mediators that are synthesized peripherally or in the brain may affect the nervous regulation of animal body systems. For example, it has been found that non-specific pro-inflammatory stimuli as well as treatment with several cytokines may cause depressive behavior, disturbances in energy balance and alterations in the circulatory system. On the other hand, knockout of genes for pro-inflammatory cytokines or administration of anti-inflammatory mediators may normalize the pathological changes. In the present manuscript we will review studies that imply the common neuroinflammatory pathogenesis of cardiovascular diseases, depression and energy balance disorders.
引用
收藏
页码:228 / 235
页数:8
相关论文
共 106 条
  • [1] Interferon-induced depression in chronic hepatitis C: A review of its prevalence, risk factors, biology, and treatment approaches
    Asnis, GM
    De La Garza, R
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (04) : 322 - 335
  • [2] Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction
    Balbay, Y
    Tikiz, H
    Baptiste, RJ
    Ayaz, S
    Sasmaz, H
    Korkmaz, S
    [J]. ANGIOLOGY, 2001, 52 (02) : 109 - 114
  • [3] TUMOR NECROSIS FACTOR
    BALKWILL, FR
    [J]. BRITISH MEDICAL BULLETIN, 1989, 45 (02) : 389 - 400
  • [4] Passage of cytokines across the blood-brain barrier
    Banks, WA
    Kastin, AJ
    Broadwell, RD
    [J]. NEUROIMMUNOMODULATION, 1995, 2 (04) : 241 - 248
  • [5] BEISEL WR, 1981, CANCER RES, V41, P3797
  • [6] Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods
    Beretta, E
    Dhillon, H
    Kalra, PS
    Kalra, SP
    [J]. PEPTIDES, 2002, 23 (05) : 975 - 984
  • [7] Immune-neuro-endocrine interactions: Facts and hypotheses
    Besedovsky, HO
    DelRey, A
    [J]. ENDOCRINE REVIEWS, 1996, 17 (01) : 64 - 102
  • [8] SYNERGY BETWEEN TUMOR-NECROSIS-FACTOR CT AND INTERLEUKIN-1 IN THE INDUCTION OF SICKNESS BEHAVIOR IN MICE
    BLUTHE, RM
    PAWLOWSKI, M
    SUAREZ, S
    PARNET, P
    PITTMAN, Q
    KELLEY, KW
    DANTZER, R
    [J]. PSYCHONEUROENDOCRINOLOGY, 1994, 19 (02) : 197 - 207
  • [9] Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes
    Bluthe, RM
    Michaud, B
    Kelley, KW
    Dantzer, R
    [J]. NEUROREPORT, 1996, 7 (15-17) : 2823 - 2827
  • [10] Is hypertension an inflammatory process?
    Boos, Christopher J.
    Lip, Gregory Y. H.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (13) : 1623 - 1635